skip to main content
Idioma:
Refinado por: data de publicação: Após 2009 remover Segal, Amiel remover assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A 67-Year-Old Woman with BRCA 1 Mutation Associated with Pancreatic Adenocarcinoma
A 67-Year-Old Woman with BRCA 1 Mutation Associated with Pancreatic Adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A 67-Year-Old Woman with BRCA 1 Mutation Associated with Pancreatic Adenocarcinoma

Lowery, Maeve ; Shah, Manish A. ; Smyth, Elizabeth ; Epstein, Andrew ; Segal, Amiel ; Rosengarten, Ora ; Isacson, Rut ; Drukker, Lior ; Keinan, Anner ; Rachkiman, Meir ; Reissman, Petachae ; Gabizon, Alberto ; Kelsen, David ; O’Reilly, Eileen M

Journal of gastrointestinal cancer, 2011-09, Vol.42 (3), p.160-164 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
2
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

Lowery, Maeve A. ; Kelsen, David P. ; Capanu, Marinela ; Smith, Sloane C. ; Lee, Jonathan W. ; Stadler, Zsofia K. ; Moore, Malcolm J. ; Kindler, Hedy L. ; Golan, Talia ; Segal, Amiel ; Maynard, Hannah ; Hollywood, Ellen ; Moynahan, MaryEllen ; Salo-Mullen, Erin E. ; Do, Richard Kinh Gian ; Chen, Alice P. ; Yu, Kenneth H. ; Tang, Laura H. ; O'Reilly, Eileen M.

European journal of cancer (1990), 2018-01, Vol.89, p.19-26 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma

O'Reilly, Eileen M. ; Lee, Jonathan W. ; Lowery, Maeve A. ; Capanu, Marinela ; Stadler, Zsofia K. ; Moore, Malcolm J. ; Dhani, Neesha ; Kindler, Hedy L. ; Estrella, Hayley ; Maynard, Hannah ; Golan, Talia ; Segal, Amiel ; Salo‐Mullen, Erin E. ; Yu, Kenneth H. ; Epstein, Andrew S. ; Segal, Michal ; Brenner, Robin ; Do, Richard K. ; Chen, Alice P. ; Tang, Laura H. ; Kelsen, David P.

Cancer, 2018-04, Vol.124 (7), p.1374-1382 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.